Big Weekly Winners: Swing Trading with PowerRatings

The previous trading week ended with the market oversold after the excessive selling last Wednesday and Thursday. We opened this week’s trading on Monday with speculation around Europe and the looming ‘fiscal cliff’ increasingly becoming the center of focus. Volatility began to implode on Monday, and by Tuesday all four major US indices were trading under their 200-day moving averages. By Thursday the market had reached extremely oversold territory with a mounting concern over a bear market taking hold. Friday’s trading began with the market washed-out and still extremely oversold. The major sectors began to pull away while all eyes were on the lookout for the long awaited bounce. We wrapped this week’s trading with the major indices still under their 200-day MA and with a watchful eye out for confirmation of whether or not a bull market is still in place. The top-performing stocks from this trading week came from the healthcare and services sectors.

The stocks in this week’s Big Weekly Winners: Swing Trading with PowerRatings all earned PowerRatings of 8 or higher one week ago on November 9, 2012.

To learn more about PowerRatings, including how to swing trade stocks and ETFs with PowerRatings, click here.

Performance of 11/09/12 – 11/16/12 Trading Week

Infinity Pharmaceuticals, Inc. (INFI)

INFI chart

Shares of Infinity Pharmaceuticals, Inc. surged this week following positive results from a phase 1 study of a new arthritis medication. INFI entered the week trading above its 200-day moving average and rose 9.5% during Monday’s trading, 3.6% on Tuesday, and continued to climb on Thursday and Friday for a weekly gain of 20.12%.

  • 11/09/12 Entry Price: 18.34 with a PowerRating of 8
  • 11/16/12 Exit Price: 22.03
  • Gain: 20.12%

GameStop Corp. (GME)

GME chart

GameStop Corp. shares had a strong week amid a better-than-expected Q3 report and boosted sales off of the latest Call of Duty game from Activision. GME ended last week’s trading on Friday above its 200-day MA in oversold territory. GME saw gains of over 4% on Monday, Thursday, and Friday, with small gains on Tuesday and Wednesday as well to close the week up over 15%.

  • 11/09/12 Entry Price: 22.11 with a PowerRating of 8
  • 11/16/12 Exit Price: 25.55
  • Gain: 15.56%

Synta Pharmaceuticals Corp. (SNTA)

SNTA chart

Shares of Synta Pharmaceuticals Corp began this last week trading above its 200-day MA and opened Monday with a spike in insider buying. SNTA rallied throughout the week to close in very overbought territory with a solid double-digit weekly gain.

  • 11/09/12 Entry Price: 6.76 with a PowerRating of 9
  • 11/16/12 Exit Price: 7.69
  • Gain: 13.76%


Learn how to swing trade using PowerRatings! Click here to launch your free trial to PowerRatings today. Free trials include full access to our entire database of stocks, ETFs and leveraged ETFs, as well as swing trader training videos.

Joshua Glasgall is Editor in Chief of Connors Research

Have You Switched to ConnorsRSI?

ConnorsRSI is the first Quantified Momentum Indicator -- the next-generation improvement to traditional RSI indicators. At Connors Research, we are using it as an overlay to many of our best strategies to make them even better -- now you can, too.

Enter your email address to get your FREE download of our Introduction to ConnorsRSI - 2nd Edition - Trading Strategy Guidebook with newly updated historical results.

Disclaimer: The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.